← Back to Search

Bupivacaine Injection for Postoperative Pain (CLAPPS Trial)

Phase 4

Waitlist Available

Research Sponsored by Northwell Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 18-24 hours

Awards & highlights

CLAPPS Trial Summary

This trial looked at whether or not locals given in the incision site can help with postoperative pain on a laparoscopic/robotic-assisted sacrocolpopexy.

CLAPPS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 18-24 hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~18-24 hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and 18-24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Likert-pain scale score on postoperative day one

Secondary outcome measures

Brief Pain Inventory

Narcotic Usage

CLAPPS Trial Design

2Treatment groups

Experimental Treatment

Group I: subcutaneous infiltration pre-incisionExperimental Treatment1 Intervention

Marcaine (bupivacaine) injected in the umbilical port site subcutaneously, while in the other 4 sites injection under direct visualization

Group II: subcutaneous infiltration post-incisionExperimental Treatment1 Intervention

local anesthetic infiltrated subcutaneously at the end of the procedure after trocar removal and after skin closure with suture

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Bupivacaine

FDA approved

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Northwell HealthLead Sponsor

458 Previous Clinical Trials

470,804 Total Patients Enrolled

4 Trials studying Postoperative Pain

372 Patients Enrolled for Postoperative Pain

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What ailments is Bupivacaine Injection typically utilized to treat?

"Bupivacaine Injection is deemed an effective solution for treating permphigus, acute nonspecific tenosynovitis, and general anesthesia."

Answered by AI

Has Bupivacaine Injection received regulatory clearance from the FDA?

"Our team at Power awarded Bupivacaine Injection a score of 3, as it has already been authorized and is currently undergoing Phase 4 trials."

Answered by AI

Is Bupivacaine Injection undergoing any other research studies presently?

"Currently, there are 109 investigations related to Bupivacaine Injection. Of those studies, 18 have reached Phase 3 and involve 144 different locations primarily located in the city of Philadelphia, Pennsylvania."

Answered by AI

What is the upper limit of participants in this clinical research?

"Affirmative. Clinicaltrials.gov displays evidence that, from July 30th 2021 to October 6th 2022, this clinical trial is searching for 128 patients over 3 sites."

Answered by AI

Does this clinical trial continue to seek out participants?

"Clinicaltrials.gov currently displays that this clinical trial is in the process of recruiting participants, having first been published on July 30th 2021 before being recently updated on October 6th 20212."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Pre-incision Versus Post-incision Local Anesthetic During Robotic Sacrocolpopexy

Harvey Winkler, MD 2021. "Pre-incision Versus Post-incision Local Anesthetic During Robotic Sacrocolpopexy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04996251.